Health industries quarterly insights: Q1 2025
The health industries quarterly offers insights on accounting and reporting hot topics impacting the industry.
Keeping emerging growth companies and their leaders ahead of the curve
Ambition is your fuel for growth. Agility is your superpower. Your skills to innovate and disrupt the status quo have propelled your business to where it is today.
Whether you’re in the early stages of funding or preparing for the capital markets — you need a passionate community of solvers who deeply understand your aspirations and can pave the way to building trust with your stakeholders and deliver measurable, sustainable outcomes. Our team brings the right people and technology together to nimbly support you in your growth and conversion from a private to public company.
Clearing the path from private to public
From early funding stages to preparing for the capital markets, our team brings world-class expertise in key focus areas for emerging companies:
- Complex revenue recognition
- Stock-based compensation
- Debt and equity financing
- SEC reporting
- Private valuation
- Internal controls
- IPO readiness
- Domestic and international taxation
- Mergers and acquisitions
Services built around you
Be supported by a dedicated team and service approach designed specifically for early stage and emerging companies, your agenda, your stakeholders, and where you want to go next.
Staying compliant, agile and resilient
Rely on an ecosystem of tech-enabled solutions, supported by PwC’s brand and global resources, to deliver high-quality outcomes faster.
Proactively plan for what’s ahead
Tap into the resources and insights that will help you uncover, untangle and understand what’s ahead.
With you when the opening bell rings
Going public is a monumental decision that forever changes how a company operates. The process can be time-consuming, expensive, and divert management's attention from daily operations. Preparation is crucial, and that's where we come in. Our experience has shown that without proper planning, key issues can strain resources.
Insights
Loading...
Considering an IPO? First understand the costs
Insight into the costs of an IPO can help outline an IPO to the board of directors, employees and other stakeholders within the company.
Next in pharma 2025: The future is now
Four strategic bets and a suite of capabilities for the pharma industry to help you determine how your company can create value in the future.
Next in tech 2025: Thriving amid disruption with data, AI and agility
Explore key trends in the tech sector for 2025, including AI, business model reinvention, thriving amid regulatory challenges and evolving market dynamics.
TMT insights: Financial reporting and accounting quarterly﹘Q4 2024
PwC’s TMT insights financial reporting and accounting quarterly Q4 2024 report features emerging trends affecting technology, media and telecommunications companies.
Six Considerations for Private Companies on Retail Investor Interest in Private Markets
For emerging companies, the heightened interest from retail investors could have an impact on capital-raising strategies, valuations, governance, taxes and other areas.
Five key oversight considerations for emerging biotechnology company board members
Emerging biotech companies are poised to revolutionize healthcare, with board members playing a critical role in navigating this complex, regulated industry.
Pharmaceutical and life sciences: US Deals 2025 outlook
With a confluence of factors pointing towards significant deal opportunities in 2025, industry players must remain agile and ready.
Capital Markets 2025 outlook
US public markets are gearing up for a 2025 resurgence driven by interest rate cuts, pent-up investor demand and a growing backlog of IPO hopefuls.
Transforming healthcare: 3 key takeaways on value-based care for emerging companies
Emerging healthcare companies can transform value-based care by leveraging tech, data analytics and patient engagement to improve outcomes and reduce costs.
How emerging companies are navigating growth in the health industry
PwC specialists discuss how emerging companies are navigating the complexities of capital raising, product development and harnessing the power of AI to enhance patient outcomes in the health industry.
Helping unlock financial potential: exploring five strategic financing alternatives for biotech companies
Biotechs, in their pursuit of additional funds for vital operations and research, should carefully select their funding method based on their stage, risk tolerance, and existing capital structure.
Loading...
Contact us
Chris Stephens
Technology, Media & Telecommunications - Emerging Company Solutions Leader, PwC US
Technology, Media & Telecommunications - Emerging Company Solutions Markets Leader, PwC US
Follow us
